Abstract. Alpha-synuclein ( -Syn) is a protein with high tendency to convert into toxic aggregates that are involved in Parkinson's Disease (PD). The conversion of -Syn into toxic aggregates may associate with bio-membranes and the interaction between -Syn and bio-mimic liposomes can trigger the neurotoxicity. Some inhibitors of -Syn aggregation are challengeable drugs. Using nano carriers such as nanoliposomes may overcome such challenges. Nevertheless, there are few studies on nanoliposomes e ects on neuronal cells and -Syn. Herein, we investigated the neurotoxicity and brinogenesis of neutral charged nanoliposomes. Thin layer evaporation method and hydration method was employed to formulate the nanoliposomes from Dipalmitoylphosphatidylcholine to the size of 100 nm.
Introduction
Proteins misfolding and aggregation are pathognomonic for nearly all age-related neurodegenerative the deposits known as Lewy bodies and Lewy neurites [8, 9] .
PD is the second most common neurodegenerative disease, and so far, various studies have reported on the role of -Syn in the initiation and spreading of neurodegeneration in PD. The degeneration of dopaminergic neuronal cells has been shown to be connected with the development of -Syn brillation [10] . Hence, there is a considerable interest in inhibiting -Syn bril formation, which can be a virtuous avenue to impede the development of PD [11] [12] [13] .
Nowadays, nanoparticles are immensely considered a promising strategy in drug delivery systems [14] . Remarkably, engineered nanomaterials not only suggest novel structural, optical, and electronic properties in diagnostics and therapy of di erent diseases [15] , but also deliver several functionalities due to their extended surface area, diverse surface chemistry, and unique pharmacokinetics [15, 16] . In fact, these characteristics bring about mighty potency to increase the solubility, concerning the hydrophobic drugs and stability of both hydrophobic and hydrophilic drugs in the aqueous medium of the body, and carry them to the target tissue [17] .
Liposomes, as a major class of macromolecular carriers, owing to several merits including biocompatibility, low immunogenicity, protecting cargo against enzymatic degradation, and easy surface modi cation, have been interestingly aimed at targeted delivery [18] . Moreover, the nature and structure of liposome, containing a core of aqueous solution with two layers of phospholipid, gives it a unique capacity to deliver both hydrophobic and hydrophilic drugs [15] . This means that nanoliposomes are signi cantly regarded as nano carriers with high capacity for encapsulation of drugs.
Nanoliposomes may themselves possess an aptitude to be utilized as a substance for disease treatment [19, 20] . According to the estimations, less than half of the drugs used in the treatment of human diseases are hydrophobic with very low solubility in body uids; thus, the requisite for a high dose and frequency of consumption is a challenge concerning the use of these drugs. Furthermore, sometimes, in order to raise the solubility of the drugs, chemical modi cation is required, causing side e ects. In addition, a drug overdose and its high intake can a ect non-target tissues [21, 22] . Therefore, the use of nanoliposomes in overcoming such problems is applicable. So far, most reports corresponding to Food and Drug Administration (FDA) have con rmed that liposome-based drug have been focused on cancer treatment [23, 24] .
To date, some studies have been reported regarding the use of nanoparticles in amyloid diseases, PD and AD, to alleviate toxicity in the course of brillation process [25, 26] . Nanoliposomes are respectable candidates for drug delivery in amyloid diseases due to their phospholipid-based structure, compatibility with the body's system, and minute size, making them pass across blood brain barrier easily [27] . However, given the aggregated species of -Syn transferring from cell to cell, causing cell degeneration [28, 29] , assessment of nanoliposome impact on neurons cells sounds essential before being used as a drug carrier.
Hence, considering that few reports are available on the e ects of nanoparticles on neuronal cells and -Syn, the aim of this study is to investigate the cytotoxic e ects of neutral charged nanoliposome in di erent concentrations (35, 70, 140, 280 , 560, 1120, 1500, and 3000 M) alone and when pre-incubated with -Syn on dopaminergic cell lines, PC12 and SHSY5Y. The nanoliposome was formulated from Dipalmitoylphosphatidylcholine (DPPC) with the size of 100 nm, and its e ect on the -Syn brillation was assessed. Subsequently, the neurotoxicity ofSyn in the presence of nanoliposomes was monitored using MTT and LDH assays. Results extracted from this study showed that neutrally-charged nanoliposome has an acceptable potential as a drug carrier in the neurodegenerative disorders associated with -Syn aggregation. Moreover, having high capacity to transfer both hydrophobic and hydrophilic small molecules, the neutrally-charged nanoliposome can trigger -Syn brillation and also decrease the cell death resulting from such protein aggregated species.
2. Experimental procedure 2.1. Reagents DPPC and Mini-Extruder were prepared from Avanti Polar Lipids, Inc. (USA). Thio avin T (ThT), Congo red, and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetr azolium bromide (MTT) were purchased from SigmaAldrich (USA). LDH was acquired from Pishtazteb Co. (Iran). PC12 and SHSY5Y cell lines were acquired from Pasteur Institute (Iran). All salts and organic solvents were purchased from Merck (Darmstadt, Germany). The cell culture mediums (DMEM high glucose and DMEM-F12) and antibiotics were purchased from GibcoBRL (Life Technologies, Paisley, Scotland). Fetal bovine serum (FBS) was from Biosera (England).
Nanoliposome formulation and characterization
Thin layer evaporation and hydration procedures were employed to formulate the liposomes [30] . In brief, DPPC was dissolved in 1 mL chloroform and the thin layer of lipid was arranged using rotary evaporator with 400 Mbar pressure at 37 C at 150 rpm shaking in a round bottom ask. In the following, the lipid layer was hydrated with Phosphate Bu er Saline (PBS, pH 7.4) at 50 C for approximately 2 h. In order to convert the Multi-Vesicular Vesicles (MVV) and Multi-Lamellar Vesicles (MLV) to smaller vesicles, including Large Unilamellar Vesicles (LUV) and Small Unlilamellar Vesicles (SUV), the material was then sonicated using UP400S Ultrasonic processor (hielscher, Germany) for four times (Cycle 0.5, Amplitude 60%), each for 45 seconds with an internal rest of 30 seconds. Then, the Mini-Extruder set equipped by 100 nm lter was employed to formulate SUV in a size of 100 nm.
In the last step, size, surface charge, and form of the formulated nanoliposomes were evaluated using Zeta seizer (MAlVER, UK) and Transmission Electron Microscopy (TEM) (JEM-1010; JEOL, Tokyo, Japan).
Transmission electron microscopy
A 5 L sample of nanoliposome was relocated to a carbon-coated, glow-discharged 400-mesh grid for 30 seconds. The grids were then rinsed by two droplets of double distilled water, and stained with 1% phosphotungstic acid (pH 6.8), and blotted dry. The samples were processed for microscope observation (JEM-1010; JEOL, Tokyo, Japan) working with 60 kV and the images were obtained using an Olympus KeenView G2 camera.
Protein expression and puri cation
The pET11-D plasmid, containing human -Syn cDNA, was transformed to Escherichia coli BL21 (DE3) strain. The transformed cultures were grown overnight at 37 C in 1 L of LB medium (10 gr Tryptone, 5 gr Yeast Extract and 10 gr NaCl per liter) containing 100 g/mL of kanamycin. The sub-culture of the grown bacteria was prepared and protein expression was carried out using auto-induction according to the protocol described elsewhere [31] . To extract protein, cells were centrifuged for 20 min at 3500 rpm at 4 C. The pellet obtained by 1 L culture was then resuspended in 100 mL osmotic shock bu er (30 mM Tris-HCl, 40% sucrose, 2 mM EDTA, pH 7.2) and incubated for 10 min at room temperature followed by centrifugation for 30 min at 9000 g at 20 C. The acquired pellet was resuspended in 90 mL ice-cold deionized water followed by adding 40 L of saturated MgCl 2 and incubated on ice for 3 min. Then, the material was centrifuged for 20 min at 9000 g at 4 C, and the supernatant was collected. Precipitation of the supernatant was carried out by titration with 1 M HCl to pH 3.5 and incubated for 5 min. The supernatant was then collected by centrifugation for 20 min at 9000 g at 4 C and titrated to pH 7.5 with the drop-wise addition of 1 M NaOH. The extracted protein was ltered through 0.45 m lter and loaded onto a Q-Sepharose column (HiTrap Q H P), which was pre-equilibrated with 20 mM TrisHCl (pH 7.5). The column was rinsed with 0.1 M NaCl in bu er with three column volumes, -Syn was eluted with a NaCl gradient from 0.1-0.5 M, and the collected puri ed protein was dialyzed against deionized water.
SDS -Polyacrylamide Gel Electrophoresis (with 13% resolving gels) was employed to analyze the fractions.
Finally, the puri ed -Syn was freeze dried and stored at 20 C for the next steps.
-Syn brillation assay
-Syn was dissolved in PBS bu er (pH 7.2) in a nal concentration of 70 M supplemented by di erent concentrations of neutral charged nanoliposomes (35, 70, 140, 280 , 560, 1120, 1500, and 3000 M) in a nal volume of 150 L, added to each well of a 96-well plate with a 3 mm diameter glass bead. A sample of -Syn without nanoliposome was considered as control. Plates were sealed with a crystal clear sealing tape (Hampton Research, Aliso Viejo, CA). The brillation process was conducted at 37 C with 300 rpm orbital shaking. After a period of time, the bril formation with or without nanoliposomes was assessed by standard tests including ThT and Congo red.
Cell culture
PC12 and SHSY5Y cell lines were cultured in DMEM high glucose and DMEM-F12, respectively, which were complemented with 100 u/mL penicillin, 100 g/mL streptomycin, and 10% FBS, and incubated at 37 C in humidi ed atmosphere with 5% CO 2 and 90% humidity. Then, the cells were subcultured in 96-well microliter plates for the toxicity assays.
Toxicity assays
In order to assess the cytotoxicity of di erent concentrations of nanoliposomes alone and when preincubated with -Syn on the cell lines, MTT and LDH assays were employed as follows: 2.7.1. Cell viability assay To conduct MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide, as a colorimetric assay for evaluating cell metabolic activity revealing cytotoxicity and cell viability, the cells were seeded with density of 3 10 4 and 6 10 4 cell/ml for PC12 and SHSY5Y, respectively, and incubated in a CO 2 incubator for 24 h followed by treatment with di erent concentrations of nanoliposomes alone and when pre-incubated with -Syn (10% v/v). After that, the cultures were incubated in the same condition for more 24 h. Then, the medium was removed, the wells were washed by PBS, a freshly medium complemented with 10% (v/v) MTT stock solution (5 mg/mL in PBS) was added to each well, and the plates were incubated for 4 h in the dark. In the following, the insoluble purple formazan crystals, formed because of reducing the tetrazolium dye through cellular oxidoreductase, were dissolved in DMSO. The purple formazan product was then measured at 570 nm by Eliza reader (Expert 96, AsysHitch, Ec Austria) to re ect the number of 
2.7.2. Lactate dehydrogenase release assay Lactate dehydrogenase (LDH) is a cytosolic enzyme present in most live cells, and this experiment quantitatively measures LDH released into the media from damaged cells as an indication of cytotoxicity. Here, according to the LDH cytotoxicity assay kit, extracellular LDH in culture media was measured using an enzymatic reaction that results in the reduction of substrate. In brief, following the treatment of cells and further incubation for 24 h, a total of 100 L sample of growth media was collected and added to 1 mL of the arranged substrate from the kit. In the nal step, the absorbance was measured at 340 nm using spectrophotometer (T80 + UV/VIS, PG instruments Ltd, England) at 37 C. The LDH reaction acts as follows:
Statistical analysis
Statistical analysis was conducted using SPSS version 16.0. All experiments were carried out for three times, and the results were provided as means SD. One-way ANOVA and Unpaired Student's t-test were used to consider the statistical signi cance within the groups and between the groups, respectively. P Values < 0:05 were regarded as signi cant.
3. Results and discussion
Nanoliposome preparation and characterization
The neutrally-charged nanoliposome in a size of 100 nm diameter was formulated from DPPC using thin layer evaporation and hydration methods followed by means of sonication and mini-extruder set, as shown in Figure 1 .
To characterize the formulated nanoliposome, DLS was employed to analyze the size and Poly dispersity Index (PdI). The particle size evaluated by DLS (z-average) based on number of particles was determined for nanoliposomes prepared from the neutral charged phospholipid as 71.37 nm (PdI 0.234), as shown in diagram (Figure 2(a) ). Furthermore, the surface charge of nanoliposome was measured by potential assessment. Results indicated potential value of 1:795 0:545 mV for nanoliposome. As a result, we con rmed that nanoliposomes are neutrally charged. The outcomes of TEM analysis (Figure 2(b) ) con rmed what was achieved by DLS analysis, and revealed the spherical and unilamellar morphology of the nanoliposomes. In addition, the results obtained from TEM analysis demonstrated that the sizes of nanoliposomes were nearly in the range of 60-90 nm.
The stability of nanoliposomes was assessed by evaluating the changes in the size of nanoliposomes throughout 21 days at 4 C. No considerable evidence was observed in the change of nanoliposomes size where stored at 4 C over a period of 21 days (Table 1 ).
E ect of the neutral charge nanoliposome on -Syn brillation
The molecular basis of PD appears to be tightly associated with the aggregation of -Syn into amyloid brils, which is believed to play an important role in PD and some other amyloid-related disorders [6, [32] [33] [34] . Results obtained from the research on various cells and animal models o er that the prevention of amyloid aggregation is worthwhile to alleviate the symptoms of amyloidosis [35, 36] . Accordingly, numerous studies have been reported concerning the compounds to inhibit and/or disaggregate -Syn aggregation, which could be considered a therapeutic strategy towards these neurodegenerative amyloid disorders. Some of the anti-aggregating components, which have so far been identi ed to have a potential use in the treatment of amyloidosis, include antibodies, synthetic peptides, chemically-synthesized compounds, small organic molecules, and heat shock proteins [37] [38] [39] [40] [41] . Recently, nanoparticles have been signi cantly considered in not only the study of protein aggregate recognition and destruction [42] [43] , but also in the realm of protein brillation [44] [45] [46] and inhibition of bril formation [47] . According to previous studies, the interaction of nanoparticles with proteins can lead to perturbation of both protein structure and function. Nanoparticles' biophysicochemical properties, containing size, morphology, chemical composition, surface charge, and hydrophobicity, possess important roles in the brillation process through their impact on proteins conformation [46] . Therefore, a general trend of response in the brillation is not expected by dissimilar nanoparticles. It means that the interaction of nanoparticles and amyloid proteins might result in di erent outcomes, including inhibition or facilitation of amyloid formation, or even be ine ective.
Here, the formulated neutrally-charged nanoliposomes (as described in previous section) were applied to investigate the nanoliposomes impact on -Syn brillation using ThT uorescence intensity, Congo red absorbance, and uorescents microscopy images.
To determine the e ect of nanoliposome on the protein brillation, -Syn was treated with di erent concentrations of nanoliposome and incubated for 24 and 48 h at 37 C. Rate of -Syn brillation in the presence or absence of nanoliposome was measured based on the level of ThT uorescence emission (Thio avin T-binding assay) (Figure 3(a) ). The emission of ThT uorescence is relevant to -sheet structure and bril formation. The results indicated that nanoliposome almost permanently decreased -Syn brillation in a concentration-independent manner. In addition, for more control samples, the monomer of -Syn, monomer incubated with 3000 M of nanoliposome for 1 min, 3000 M of nanoliposomes alone, 3000 M of nanoliposomes with ThT were assessed by the uorimetry to evaluate whether they raise ThT emission and could interfere with the results or not. No emission was taken at 480 nm for each sample, indicating no interference of ThT with nanoliposome (data not shown). Congo red analysis also con rmed ThT results. As elucidated from Figure 3(b) , a detectable red shift was observed in the -Syn incubated without nanoliposomes rather than the protein treated with nanoliposomes.
To analyze the morphology of -Syn aggregates with or without nanoliposomes, uorescent microscopy images were taken after 24 h of incubation (Figure 3(c) ). The noticeable -Syn bril extensions were detected in the -Syn sample alone (Figure 3(c.1) ), while the protein treated with nanoliposomes displayed lower brillation (Figure 3(c.2-9) ).
The neutral charge nanoliposomes formulated here demonstrated to have no inducing e ect on the bril formation. In fact, they were shown to have the potential to decrease such a phenomenon. However, there are still vague features in the eld of interactions between nanoparticles and amyloid proteins. More studies are required to elucidate the mechanism of bril formation at the molecular level.
Neurotoxicity of nanoliposomes and nanoliposomes pre-incubated with -Syn
To investigate nanoliposomes toxicity as well as capability of nanoliposomes to hamper -Syn aggregatesmediated cellular toxicity, MTT and LDH assays were performed using PC12 and SHSY5Y cell lines. MTT, a tetrazolium salt, is reduced into insoluble formazan crystals by mitochondrial dehydrogenase in living cells. At rst, the cytotoxic potential of nanoliposome on PC12 and SHSY5Y cells was assessed.
Results indicated that nanoliposome had no considerable cytotoxic impact on the two kinds of cell lines in di erent concentrations ranging from 35-3000 M (Figure 4(a) ). Nonetheless, the susceptibility of the cell lines seems to be slightly di erent from each other while being treated with nanoliposomes. In SHSY5Y cells, at the concentrations of 1500 and 3000 M of nanoliposomes, a slight enhancement was observed in cell proliferation. It can be presumed that this increase might be correlated to nanoliposomes' role as a sca old, which leads to cell growth or as a nutrition source for cells. With this interpretation, it has been recently identi ed that oxidation of fatty acids is essential for malignant glioma cells (Glioma is of primary malignant brain tumor in adult) in which targeting this metabolic pathway leads to decreasing energy, and consequently reducing cell proliferation. In other words, besides glucose, the cancer cells use lipid for their respiratory activity [48] .
In the following, the neurotoxicity of -Syn preincubated with varied concentrations of nanoliposome was evaluated on both PC12 and SHSY5Y cell lines.
-Syn aggregates showed to reduce the cell viability of PC12 and SHSY5Y cells with di erent rates, which validated the dissimilar susceptibility of two kinds of cell line ( Figure 5 (a) and Figure 6(a) and (b) ). However, pre-incubation of -Syn with nanoliposome led to modulating the -Syn aggregates-mediated neurotoxicity towards lower cytotoxic e ect.
Simultaneously, the LDH assay supported the results obtained from MTT for both experiments, including the neurotoxicity of nanoliposome alone (Figure 4(b) ) and -Syn pre-incubated with nanoliposome ( Figure 5(b) ). LDH is assessing the integrity of cell membrane, indicating live cells. The cell membrane is the rst part dealing with external agents and the main objective of toxic brils. The aggregates involve membrane disruption, and so the cytotoxicity is more observable in here. Results obtained here well highlight the safety of the formulated nanoliposomes on dopaminergic cell lines.
The toxic e ects of nanoparticles on human health have been one of the chief concerns of nanoparticles applications [49] . The studies have well demonstrated that nanoparticles can in uence biological behavior at the cellular and protein levels. Nanoparticles report to have carcinogenic e ects, which lead to DNA impairment, and induce in ammatory lesions [50] . Therefore, there is an essential requisite to assess the toxicity of nanoparticles before applying them as safe components in medical and pharmaceutical industries. The cytotoxicity of nanoparticles is mainly associated with particle parameters containing size, shape, chemical composition (purity, electronic properties, or crystallinity), surface structure (surface coatings-inorganic or organic), charge, hydrophobicity, and aggregation behavior [51, 52] . Nevertheless, biological factors, including type of cells, and culture circumstances, such as temperature, culture medium components and cell density, can a ect cytotoxicity [52] .
The surface charge seems to possess more complexity related to cytotoxicity compared with other factors such as size [53] . The cytotoxicity of liposomes has been shown to be connected with their charge and size [54] . Considering the similar size, neutral liposomes have been shown to have less toxicity than charged liposomes, whereas the positive types/cationic liposomes are more toxic than negative ones in cells [54] [55] [56] [57] . Cationic liposomes involved with reactive oxygen intermediates destroy plasma-membrane integrity, mitochondria, and lysosomes and increase the number of autophagosomes in contrast to anionic particles, resulting in intracellular damage [52, 56] . Therefore, the toxicity of some formulated liposomes, especially that incorporating cationic agent is noticed as the major disadvantage in the medical application. However, in some cases, cationic liposomes have, in turn, been suggested to be an e cient tool for the selective delivery of antiangiogenic drugs to target tissue [58] .
Since it has well been recognized that the terms of nanoliposomes formulation interfere with the cell cytotoxicity, the parameters, including kind of lipid, nature and amount of the charged component, and the liposome size, are vital to be considered to achieve nanoliposomes formulated with minimum toxicity [59] . Moreover, the amount and type of nanoliposome with the ratio of lipid to protein are involved in protein brillation [19, 20] . Given that DPPC has been shown to have less toxic e ect than other phospholipids, such as DMPC [59] , in the present study, DPPC was utilized to formulate neutrally-charged nanoliposomes in order to assess nanoliposomes e ect on the protein brillation and neuron toxicity. There are some controversial debates concerning the toxicity of di erent aggregate species of proteins. Numerous studies have been reported that the presence of early aggregate species, known as oligomers, would lead to cell death. With respect to this fact, some are advocates for a theory that inhibition of the brillation procedure can lead to the prevention of cell death and disease progress [11] , whereas others believe that induction of oligomers towards mature brils modulates cell degeneration. Based on the latter, nanoparticles, especially those that possess an ability to accelerate brillation, would be proper candidates to reduce oligomers, and consequently hinder cell death [26] . Furthermore, a recent study has suggested that the trend of brillation and aggregation process plays a crucial role in cell toxicity, and inhibiting bril growth and seeding aptitude may act as a viable strategy to protect cells from degeneration [10] . Finally, according to the existing con icts, more investigations are required to elucidate the mechanism of -Syn pathologic species and its impact on cell death while being treated by nanoparticles.
Conclusion
At present, engineered nanoparticles are recognized as promising and mighty tools to control or treat neurodegenerative diseases if their safety, biocompatibility, and biodegradability can be addressed. In this report, we have evaluated the toxicity of nanoliposomes formulated with neutral charge towards two dopaminergic cell lines including PC12 and SHSY5Y. The e ect of nanoliposomes on -Syn aggregation has been also assessed. Our results showed that the nanoliposomes formulated from DPPC with neutral charge have no neurotoxic e ect on the cell lines applied here and can additionally prevent -Syn brillation. Nanoliposomes pre-incubated with -Syn could, in turn, decrease the cell toxicity, con rming nanoliposomes bene ts in curing amyloid-related disease. It is clear from the current study that nanoliposomes can be perceived as a potent nano carrier with no neurotoxicity to transfer small molecules, which have the potential to inhibit bril formation in the treatment of PD and other synucleinopathy diseases. 
